This site is operated by a business or businesses owned by Informa PLC and all copyright resides
with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in
England and Wales. Number 8860726.
The new FDA guidance document for ISO 10993-1 focuses on a risk based approach to biocompatibility. The first step is to develop a BEP. This webinar will go over the thought process and information needed to develop a useful testing plan.